A single Arm, Multicenter, Prospective, Clinical study to evaluate efficacy and safety of MAR/HO-2 oil in mild to moderate Hair loss in females - NI

Marico Ltd0 个研究点目标入组 51 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Subjects suffering from mild to moderate hair loss (by comb test).
•2. Subjects who are infrequent hair oil users
•3. Subjects who are willing to give informed consent and ready to comply with the protocol
•4. Subjects who are ready to provide regular follow ups till the completion of the study

•1. Subjects with severe Hair fall due to any clinically significant disorders like anemia, thyroid disorders etc.
•2. Subject with severe dermatological disorders of the scalp that might interfere with the study evaluation
•3. Subjects with recent disease history like, malaria, typhoid, jaundice and scalp diseases and subjects who in the opinion of the investigator are not eligible for enrollment in the clinical study
•4. Subjects who have regularly used anti-hair fall treatment with hair oils over the last 6 months.
•5. Subjects who have previously undergone hair transplantation procedures
•6. Subjects on systemic steroids for more than 14 days within 2 months prior to enrollment.
•7. Subjects on immunosuppressive drugs
•8. Known cases of Hypersensitivity to hair oil contents
•9. Subjects who have participated in any other clinical study since last 3 months
•10. Subjects who are reported pregnant or planning a pregnancy or lactating.
•11. Menopausal Women

发起方